T-Cell and NK-Cell Neoplasm — Trials

T-Cell and NK-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,103 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04809233	Expanded Access to Tipifarnib(Kuraoncology)	available	—	—	Kura Oncology, Inc.INDUSTRY	0	Jun 29, 2026	clinicaltrials
NCT07215832	Karyopharm Expanded Access Program for Selinexor(KEAP)	available	—	—	Karyopharm Therapeutics IncINDUSTRY	0	Mar 2, 2026	clinicaltrials